FDA Approves Nivolumab for Head and Neck Cancer



The FDA has approved nivolumab for squamous cell carcinoma of the head and neck that has progressed during chemotherapy with a platinum-based drug or that has recurred or metastasized after platinum-based chemotherapy.



Source link

Comments are closed.